Charles River Laboratories International (CRL) Revenue (2009 - 2025)

Charles River Laboratories International's Revenue history runs 17 years deep, the most recent figure standing at $994.2 million for Q4 2025.

• In Q4 2025, Revenue fell 0.83% year-over-year to $994.2 million; the TTM figure through Dec 2025 stood at $4.0 billion (down 0.85% YoY), while the FY2025 annual figure was $4.0 billion, down 0.85% from the prior year.
• Revenue was $994.2 million for Q4 2025 at Charles River Laboratories International, down from $1.0 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $1.1 billion in Q4 2022 to a low of $824.6 million in Q1 2021.
• Historically, Revenue has averaged $985.6 million across 5 years, with a median of $1.0 billion in 2024.
• The sharpest annual moves came in 2021 and 2023: Revenue surged 33.99% in 2021, then declined 7.85% in 2023.
• A 5-year view of Revenue shows it stood at $905.0 million in 2021, then gained by 21.52% to $1.1 billion in 2022, then fell by 7.85% to $1.0 billion in 2023, then dropped by 1.08% to $1.0 billion in 2024, then dropped by 0.83% to $994.2 million in 2025.
• The last three Revenue figures came in at $994.2 million (Q4 2025), $1.0 billion (Q3 2025), and $1.0 billion (Q2 2025), per Business Quant data.